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Carotid-femoral pulse-wave velocity (cfPWV) is the reference standard measure of central arterial 
stiffness. However, it requires assessment of the carotid artery, which is technically challenging, 
and subject-level factors, including carotid artery plaque, may confound measurements. A 
promising alternative that overcomes these limitations is heart-femoral PWV (hfPWV), but it is not 
known to what extent changes in cfPWV and hfPWV are associated. 
OBJECTIVES 
To determine, (1) the strength of the association between hfPWV and cfPWV; and (2) whether 
change in hfPWV is associated with change in cfPWV when central arterial stiffness is perturbed.  
METHODS 
Twenty young, healthy adults (24.0 [SD: 3.1] years, 45% female) were recruited. hfPWV and 
cfPWV were determined using Doppler ultrasound at baseline and following a mechanical 
perturbation in arterial stiffness (120mmHg thigh occlusion). Agreement between the two 
measurements was determined using mixed-effects regression models and Bland-Altman 
analysis. 
RESULTS 
There was, (1) strong (ICC >0.7) agreement between hfPWV and cfPWV (ICC= 0.82, 95%CI: 
0.69,0.90), and, (2) very strong (ICC >0.9) agreement between change in hfPWV and cfPWV 
(ICC = 0.92, 95%CI: 0.86,0.96). cfPWV was significantly greater than hfPWV at baseline and 
during thigh occlusion (both P <0.001). Inspection of the Bland-Altman plot, comparing cfPWV 
and corrected hfPWV, revealed no measurement magnitude bias. 
DISCUSSION 
The current findings indicate that hfPWV and cfPWV are strongly associated, and that change in 
cfPWV is very strongly associated with change in hfPWV. hfPWV may be a simple alternative to 
cfPWV in the identification of cardiovascular risk in clinical and epidemiological settings.  
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Pulse wave velocity (PWV) is the gold standard assessment of arterial stiffness and is widely 
used in epidemiological research to estimate cardiovascular disease (CVD) risk [1]. Carotid-
femoral PWV (cfPWV), a measure of aortic stiffness, is the reference standard, being a strong 
independent predictor of CVD risk in both general [2,3] and patient populations [4]. Assessments 
of cfPWV can be performed with accuracy and precision using tonometric[5], oscillometric [6,7]  
or Doppler ultrasound technologies [8-10]. However, regardless of the approach, applanation or 
imaging of the carotid artery is required. This can be technically challenging in certain populations, 
including persons who are obese and those with advanced carotid artery atherosclerosis [11] and 
this likely limits its clinical use [12]. Also, the carotid artery is not consistent with the path of blood 
flow for the region of interest - the aortic-illiac pathway. As such it is assumed that the timing of 
the heart to carotid pressure wave is the same as that from the heart to the descending aorta 
when calculating cfPWV [13]. Finally, cfPWV does not encompass the proximal aorta [14,15], the 
distensibility of which is a predictor of CVD risk and mortality [16]. One promising alternative 
measure of central arterial stiffness that overcomes these limitations is heart-femoral PWV 
(hfPWV).  
 
PWV is calculated by measuring the pulse transit time (PTT) for the arterial waveform to pass 
between two points of a measured distance. For, hfPWV, PTT can be calculated as the time 
between the R wave of an electrocardiogram (ECG) and the foot of the femoral pressure 
waveform. The hfPWV approach confers a number of potential advantages over cfPWV: i) it is 
simpler to conduct, as the measurement is not dependent on assessment of the carotid artery; ii) 
the measurement path is consistent with the blood flow path; and, iii) it incorporates the proximal 
aorta. Although measures of hfPWV have previously been used as a clinical or epidemiological 
cardiovascular monitoring tool [17-22], only two studies have determined its association with the 
criterion, cfPWV [13,23]. Both studies reported strong correlations (r = 0.81-0.83) between hfPWV 





and cfPWV in community dwelling healthy middle-aged [13] and older adults [23]. However, what 
has not been determined is to what extent change in hfPWV corresponds to change in cfPWV 
when central arterial stiffness is perturbed. Whilst hfPWV is valid, to be of utility in clinical or 
epidemiological environments it must also be demonstrated to accurately track changes in central 
arterial stiffness and therefore CVD risk.  
  
Central arterial stiffness can be artificially manipulated, including through the use of exercise [24], 
meal consumption [25] or pharmacological means [26]. But these interventions have systemic 
affects and induce changes in heart rate (HR) which confound cfPWV [27,28]. A simple, non-
invasive model that minimizes systemic hemodynamic changes and has been used by others [29] 
is the inflation of a tourniquet to a low-moderate pressure distal to the arterial segment of interest. 
This external compression obstructs forward pressure wave propagation, modifies pulse-wave 
reflection morphology, and alters blood flow profiles, distorting arterial stiffness in upstream 
vessels [29,30]. This model can be used to confirm whether hfPWV and cfPWV are able to 
similarly track changes in central arterial stiffness. The aims of this study were to determine: (1) 
the strength of the association between cfPWV and hfPWV; and (2) whether change (baseline vs. 
cuff inflation) in cfPWV is associated with change in hfPWV. 
 
METHODOLOGY 
This study is reported in accordance with CONSORT (Consolidated Standards of Reporting 
Trials) guidelines [31]. Ethical approval was obtained from the University of North Carolina at 
Chapel Hill Institutional Review Board (17-0745), and all participants provided written informed 
consent prior to participating in the study. 
 
 






To identify the upper limit for agreement between test and criterion measures, a homogeneous 
cohort of young (18-40 years of age) healthy adults were recruited to participate in the study. 
Participants were excluded if they reported any known cardiometabolic disorders, were taking 
medications known to affect cardiovascular function or reported cigarette smoking. To account 
for potential influences of hormonal status on study outcomes, premenopausal women were 
studied during the early follicular phase of their menstrual cycle or during the placebo phase of 
oral contraceptive use. 
 
EXPERIMENTAL DESIGN 
A single-visit, two condition design, in which cfPWV and hfPWV were determined at rest and 
during thigh cuff inflation. The order of conditions was not randomized to prevent the impact of 
cuff inflation on baseline measures. However, the analyst was blinded to the order of testing. After 
familiarization, participants were tested in an environmentally controlled room (temperature, 22 ± 
1◦C; relative humidity, 51 ± 2%). All participants had fasted for 12 h and were asked to avoid 
strenuous physical activity, caffeine and alcohol for 24 h before measurements. After a 20-min 
rest period in a supine position, right sided cfPWV and hfPWV were determined using Doppler 
ultrasound. A rapid inflation cuff (SC10; Hokanson Inc., Bellevue,WA, USA), placed immediately 
proximal to the right knee, was then inflated to a pressure of 120 mmHg. Following a 5-min 
stabilization period all assessments were repeated. Pilot study (n=5, 31.0 [SD: 4.4] years, 20% 
female) findings revealed that external compression of 120 mmHg permitted the greatest impact 
on lower-extremity arterial blood flow, without full occlusion. Ultrasound was used to image the 
right posterior tibial artery to ensure blood flow was maintained. In each condition, oscillometric 
pressure waveforms were recorded on the left upper arm, from which central haemodynmic 
measurements were derived. Stroke volume (SV), cardiac output (CO) and total peripheral 
resistance (TPR) were also determined. 







PULSE WAVE VELOCITY 
A LOGIQ P6 ultrasound device equipped with an 11-2 mHz linear array probe (GE Healthcare, 
Wauwatosa, USA) was used to sequentially scan and obtain ECG-gated pulse-wave Doppler 
waveforms at the right common carotid artery (CCA) and right superficial femoral artery (SFA) by 
a single trained operator. The CCA was imaged 2cm proximal to the carotid bulb and the SFA 
was imaged 2cm distal to the bifurcation from the common femoral artery. The US beam was 
placed at mid-vessel and was angled at ≤ 60˚relative to the longitudinal axis of the artery to permit 
simultaneous measurement of brachial diameter and blood velocity. An effort was made to ensure 
that the vessel clearly extended across the entire (un-zoomed) imaging plane to minimize the risk 
of skewing the vessel walls. Ultrasound global (acoustic output, gain, dynamic range, gamma and 
rejection) and probe-dependent (zoom factor, edge enhancement, frame averaging and target 
frame rate) settings were standardized. Three 10s video recordings were obtained at each 
position during which participants were asked to hold their breath to avoid any respiratory noise.  
 
An image was obtained from the beginning, middle and end of each video (i.e., 3 images x 3 
videos for each measurement site). Images were analysed offline using ImageJ (Version 1.51q, 
National Institutes of Health, Bethesda, USA) [32] by a single blinded analyst.  The interval 
between the r-wave of the QRS complex and the foot of the systolic upstroke in the Doppler 
spectral envelope was measured and averaged over at least three consecutive cardiac cycles for 
each image at carotid and femoral sites [8,33]. The foot of the Doppler waveform was identified 
by the intersection of the upstroke of the wave with the baseline of zero frequency. ECG gated 
pulse-wave Doppler waveforms at both carotid and femoral arterial sites were used to determine 
carotid-femoral PTT (cfPTT), which represented the interval of time between the foot of the carotid 
and femoral arterial waveforms and calculated as heart-femoral PTT minus heart-carotid PTT 





(Figure 1). The cfPWV arterial path length (D) was estimated by measuring the linear distance 
from the suprasternal notch to the mid-point of the probe at the SFA and subtracting the distance 
from the suprasternal notch to the mid-point of the probe at the CCA. Path length was directly 
measured, using a custom device to bypass body contours. The r-wave to the foot of the femoral 
Doppler waveform interval represented the heart-femoral PTT (hfPTT) and estimated D was the 
linear distance from the suprasternal notch to the mid-point of the probe at the SFA only. Pulse-
wave velocity was calculated as: PWV = D / PTT. 
 
Figure 1 Determination of pulse-transit time (PTT) for heart-femoral pulse-wave velocity and carotid-femoral pulse-
weave velocity measures. Carotid-femoral PTT (cfPTT) was calculated as heart-femoral PPT (hfPTT) minus heart-
carotid PTT (cfPTT). Abbreviations: PEP, pre-ejection period. 
 
MECHANISTIC EXPLANATORY VARIABLES 
It is recognized that HR, mean arterial pressure (MAP) and arterial wave reflection morphology 
can impact central arterial stiffness. Accordingly, in order to determine the systemic effects of cuff 
inflation and their potential contribution to changes in central arterial stiffness, i) central pressure 
and indices of wave reflection were determined using pulse wave analysis (PWA), and, ii) CO, 





SV and TPR were determined using plethysmography. For PWA, oscillometric pressure 
waveforms were recorded on the left upper arm by a single observer using the SphygmoCor 
XCEL device (AtCor Medical, Sydney, Austrailia), following standard manufacturer guidelines 
[34]. Each single measurement cycle consisted of a 60 s brachial blood pressure recording 
followed by a 10s sub-systolic recording. A corresponding aortic pressure waveform was then 
generated using a validated transfer function [35], from which central systolic blood pressure 
(cSBP), augmentation index (AIx), augmentation pressure (AP), forward aortic pressure (Pf) and  
backward aortic pressure (Pb) were derived. Beat-to-beat CO, SV and TPR were monitored non-
invasively at the finger (Human NIBP Nano System, Finapres Medical Systems B.V., Netherlands) 
and sampled at 200Hz via PowerLab systems (LabChart 8, ADIinstruments, Australia). Presented 
data represents the mean of three 1-minute periods at the start, middle and end of ultrasound 
data collection.    
 
SAMPLE SIZE 
Sample size estimates were conducted using G*Power 3. For calculating the association between 
measures, we elected to use a mixed model to increase statistical power by enabling repeated 
measures to be nested within each subject. Using this approach, a sample of 37 data points can 
detect a 1-tailed correlation of 0.4 (moderate) with 80% power and a 5% chance of a type 1 error. 
For a mixed model-based approach to correlation, the degrees of freedom are equal to N – 1, 
where N is the total number of participants [36]. For a sample size of 20, with 2 repeated 
measures, the degrees of freedom (number of required participants) is 40 – 1 = 39.   
STATISTICAL ANALYSIS 
Statistical analyses were performed using RKWard (2019, Version 0.7.1), a frontend to the R 
statistical package. The significance level was set a priori for all statistical procedures at α=0.05. 
Raw data are presented as mean [standard deviation (SD)] and mixed model data are presented 





as mean [95% confidence interval (95%CI)]. The corresponding author (KS) had full access to 
the data in the study and was responsible for the integrity of the data set and the data analysis. 
 
Paired t tests were used to compare baseline and cuff inflation hemodynamic responses, as well 
as measures of cfPWV and hfPWV within conditions. Effect sizes (ES) were calculated as 
Cohen’s d where <0.2 was defined as trivial, 0.2–0.3 as small, 0.4–0.8 as moderate, and >0.8 as 
large. The association between the criterion and test measurements was determined using nested 
mixed-effects regression models. This approach allowed us to maximize statistical power while 
accounting for the correlated error variances (repeated measures) and the condition (base, cuff) 
structure. Specifically, the test measure was regressed against the criterion measure and nested 
within subject and condition (base, cuff inflation). Subject and cuff intercepts were specified as 
random effects and used to estimate the between-subject (σ2s), between-condition (σ2c) and 
residual (σ2r) variance. Subsequently, the between-measurement ICC was calculated as σ2s / 
(σ2s + σ2r) and the between condition ICC as σ2s / (σ2c + σ2r). To adjudicate the strength of 
association we used existing criteria for Pearson product-moment correlation (r). Although there 
is no universal criterion, in general, r value estimates of <0.2, 0.2-0.4, 0.4–0.7, 0.7–0.9 and >0.9 
indicate negligible, weak, moderate, strong, and very strong agreement, respectively [37]. To 
ensure transparency in our statistical approach, the supplement also reports associations 
between measurements for each condition using the standard Pearson product moment 
correlation, and between measurement correlations rmcorr package for R. As hfPWV was found 
to be on a different scale to cfPWV, to permit direct comparison and visual analysis of the 
uniformity of error over the range of participant measurement values [38], hfPWV was corrected 
(hfPWVc) using the mixed model regression equation and subsequently used to generate Bland–
Altman plots with hfPWVc and cfPWV on comparable scales [38]. 
 






All participants were included in analyses and there was no missing participant data. Participant  
descriptive characteristics are presented in Table 1.  






BLOOD PRESSURE AND PWV RESPONSE TO CUFF INFLATION 
Blood pressure and PWV responses to cuff inflation are reported in Table 2. None of the 
peripheral or central haemodynamic measures were significantly impacted by cuff inflation (all P 
>0.05). There was large effect (ES >0.8) decrease in hfPWV (-0.10 m/s, 95%CI: -0.07, -0.14) and 




Figure 2 presents the comparison between hfPWV and cfPWV. There was strong between-
measurement agreement (ICC: 0.82, 95%CI: 0.69 – 0.90) and very strong between-condition 
agreement (ICC: 0.92, 95%CI: 0.86 – 0.96) for hfPWV and cfPWV comparison. Measures of 
cfPWV were significantly higher than hfPWV at baseline (mean difference: 1.9 m/s, 95%CI: 1.72 
– 2.09, P <0.001) and cuff inflation (mean difference: 1.78 m/s, 95%CI: 1.6 – 1.97, P <0.001). 
Mean bias for Bland-Altman analysis comparing cfPWV and hfPWVc was 0.02 m/s (95%CI: -0.18 
to 0.21) at baseline and -0.04 m/s (95%CI: -0.24 to 0.14) at cuff inflation. Inspection of the plots 
indicated no measurement magnitude bias at baseline or cuff inflation (Figure 3A and B). 
n=20 Mean (SD) 
Age (years) 24 (3.1) 
Female (%) 45  
Height (m) 1.7 (7.3) 
Weight (kg) 70.2 (11.4) 
BMI (kg/m2) 23.9 (2.5) 
PA (avg/mins/wk) 65.0 (21.1) 
PA Sessions (avg/wk) 4.6 (1.4) 







Table 2 Blood pressure, wave reflection, carotid-femoral pulse wave velocity (cfPWV) and heart-femoral pulse wave velocity (hfPWV) responses to cuff inflation (n 
= 20). Abbreviations: MAP, mean arterial pressure; HR, heart rate; cSBP, central systolic blood pressure; AP, aortic pressure; AIx, augmentation index; Pb, aortic 
backward wave pressure; Pf, aortic forward wave pressure; SV, stroke volume; CO, cardiac output; TPR, total peripheral resistance; ES, Cohen’s d effect size. 
  SBP DBP MAP HR cSBP AP AIx Pb Pf SV CO TPR hfPWV cfPWV 
  (mmHg) (mmHg) (mmHg) (beats min-1) (mmHg) (mmHg) (%) (mmHg) (mmHg) (ml) (l min-1) (mmHg.s) (m/s) (m/s) 
Mean                              
Rest 117 69 81 55 102 1 3 12 26 57 3.3 4.0 2.97 4.87 
120 mmHg 118 70 81 57 102 0 1 13 26 54 3.2 3.8 2.87 4.65 
Standard Deviation                           
Rest 12 5 6 9 10 3 10 3 5 10 0.6 1.0 0.24 0.45 
120 mmHg 13 6 9 10 11 7 10 5 5 11 0.6 0.7 0.20 0.45 
Condition Effect                           
β 1.28 1.25 0.15 1.35 0.70 -1.55 -2.00 0.80 -0.40 -2.80 -0.12 -0.29 -0.10 -0.22 
P 0.747 0.494 0.954 0.659 0.827 0.382 0.552 0.556 0.812 0.393 0.562 0.287 <0.001 0.013 
ES 0.05 0.11 0.01 0.07 0.03 -0.14 -0.09 0.09 -0.04 -0.14 -0.09 -0.17 -0.84 -0.43 







Ancillary analysis is provided in the supplement. Pulse transit time and arterial path length values 
for the determination of cfPWV and hfPWV are presented in Table S1. To ensure full 
transparency, Bland-Altman plots generated using uncorrected hfPWV and cfPWV are presented 
in Figure S1.  The associations between measurements for each condition are reported using 
standard Pearson product moment correlations in Figure S2. To further interrogate intra-
individual associations between change (cuff vs. baseline) in cfPWV and change in hfPWV 
repeated measures correlation was determined (Figure S3). 
 
Figure 2 Intra-class correlations (ICC) for between-measurement (i.e., overall comparison between criterion and test 
measure) and between-condition (i.e., change [cuff – base] in the test measure vs. change in the criterion measure) 
carotid-femoral pulse wave velocity (cfPWV) and heart-femoral pulse wave velocity (hfPWV) comparisons. n=20. Red 
line and red shading depict overall between-measurement agreement and standard error, respectively. Grey lines 
depict between-condition agreement. 
 
DISCUSSION 
This study investigated, (1) the strength of the association between cfPWV and hfPWV; and (2) 
whether change in cfPWV is associated with change in hfPWV. Our main findings show that there 





is a strong (ICC >0.7) agreement between hfPWV and cfPWV, and that change (baseline vs. cuff 
inflation) in hfPWV and change in cfPWV demonstrated very strong agreement (ICC >0.9).  
 
LIMITATIONS AND STRENGTHS 
The limitations and strengths of this study are addressed to best contextualize the findings. Firstly, 
a relatively homogeneous group of young, healthy participants were recruited to ascertain the  
 
Figure 3 Bland-Altman plot for carotid-femoral pulse wave velocity (cfPWV) versus corrected heart-femoral pulse 
wave velocity (hfPWVc) at baseline (A) and during 120mmHg thigh cuff inflation (B), n = 20. 
 





upper limit of agreement between changes in cfPWV and hfPWV measures, thus limiting the 
overall generalizability of our findings to populations of varying age and health states. Prior to 
clinical use, it is imperative to identify whether any inherent error, bias or variability is caused by 
the technique itself and not a consequence cardiovascular pathology. A major strength is that this 
is the first study to directly compare changes in the reference standard measure of central arterial 
stiffness, cfPWV, and a novel, simpler alternative hfPWV.  
 
COMPARISON TO LITERATURE 
In the only other studies to directly compare cfPWV and hfPWV measures [13,23], comparable 
associations (r = 0.81 – 0.83) were observed to that reported in the present study (ICC = 0.82). 
However, in contrast to Stoner et al. [23] who reported significant bias at higher PWVs, we 
observed no measurement magnitude bias between cfPWV and corrected hfPWV measures. This 
contrast may be due to the inclusion of young, healthy individuals in the present study, whereas 
Stoner et al., [23] studied a large population of older adults of varying health and disease states. 
Higher PWV values in older adults may be accompanied by greater carotid plaque prevalence, 
which could influence local arterial mechanics and vessel elasticity [39], potentially leading to 
greater error variance. Unlike cfPWV, hfPWV measures do not require carotid artery assessment 
and are therefore not confounded by the presence of plaque.  
 
The present study also extends previous findings by being the first to report that following a 
perturbation to acutely manipulate central arterial stiffness, changes in cfPWV and hfPWV also 
demonstrate very strong agreement (ICC = 0.92). In the intended absence of systemic changes, 
the reduction in central arterial stiffness is likely a consequence of lower limb blood pooling, 
induced by venous outflow occlusion, leading to a dampening of wave reflection and an 
attenuation of central pressure [40]. Of note, Stoner et al. [23] did report that sex impacted the 





agreement between hfPWV and cfPWV; with a superior agreement in women, but a greater error 
variance at higher PWV’s. It is recognized that vascular structural and functional properties differ 
between sexes [41,42] and there are divergent relationships between HR and cfPWV [43]. 
Accordingly, whilst the present study was not adequately powered to examine sex differences, 
future studies should identify if the agreement between changes in cfPWV and hfPWV is impacted 
by sex.      
 
Measures of cfPWV were significantly higher than hfPWV measures; a difference that may have 
been driven by several sources. Firstly, there is an intrinsic difference between hfPWV and cfPWV 
in the start point from which PTT is measured (see Figure 1). cfPTT is determined as the interval 
between the foot of the upstroke of carotid and femoral waveforms. Hence, PTT is inversely 
proportional to PWV, being influenced by the same arterial and haemodynamic factors. In 
contrast, hfPTT,or pulse arrival time, is determined as the interval between the r-wave of the QRS 
complex and the foot of the upstroke of the femoral waveform [8,33]. As such, hfPTT includes the 
pre-ejection period (PEP), which is the electromechanical delay associated with the conversion 
of electrical signal into mechanical pumping force and isovolumetric contraction to open the aortic 
valves [44,45]. hfPWV may therefore not represent a true PWV, consequently overestimating 
aortic PTT. One potential solution is to measure PTT from the beginning of the S segment of the 
ECG, thereby reducing the impact of PEP on hfPWV measures. However, in comparison to the 
prominent R-wave, the S-wave is susceptible to motion and measurement artifact and is likely 
less reliable. Alternatively, isovolumetric contraction time, and thus PEP, can be estimated by 
analyzing the heart to carotid waveform and using cfPWV as a surrogate for ascending aorta 
PWV [46]. But whilst this promising deductive approach demonstrated good agreement with 
echocardiography derived PEP, a number of assumptions are made, including; i) ascending aortic 
length, and ii) that the electro mechanical delay of PEP is constant and equal to the QR interval 





[46]. These assumptions may not always be appropriate, particularly within patient populations. 
Secondly, cfPWV measures do not encompass the proximal aorta [13-15]. cfPWV assessment 
employs the carotid artery, which is not consistent with the path of blood flow for the region of 
interest - the aortic-illiac pathway. To adjust for this, the arterial segment from the ascending aorta 
to the carotid artery is omitted (subtracted) from the effective path lengths used for cfPWV 
calculations [14]. In doing so, it is also assumed that the time the forward pressure wave takes to 
travel from the heart to the carotid artery is the same time it takes a simultaneous wave to travel 
the same distance from the heart to the descending aorta [13,14]. Therefore, cfPWV actually 
represents the PWV from the descending aorta to the femoral artery. Omission of the highly elastic 
proximal aorta inherently leads to cfPWV measures being higher than hfPWV measures, as the 
latter includes the whole aorta. Hickson and colleagues [47] demonstrated that exclusion of the 
aortic arch from global aortic PWV measures determined using magnetic resonance imaging 
reduced the difference between (up to 0.8m/s) and improved the agreement with cfPWV 
determined using both tonometric and oscillometric technologies. Although the inclusion of PEP 
and the ascending aorta collectively contribute to causing greater divergence, hfPWV and cfPWV 
are consistently proportionate to each other, hence their strong agreement, as reported in the 
present study and by others [13,23]. 
 
IMPLICATIONS 
Despite cfPWV being a strong independent predictor of CVD risk  [2-4], it is not widely used in 
clinical practice. Technical challenges associated with the assessment of the carotid artery, which 
can be difficult to perform in certain populations, likely limits it clinical use.  Furthermore, although 
not widely recognized, the inherent omission of the proximal aorta may overlook important 
pathophysiological information [16]. hfPWV is a simpler alternative which is less likely to be 
confounded by subject-level factors, including the presence of carotid plaque, and encompasses 
the predictive capacity of the whole aorta. Previously cfPWV and hfPWV measurements have 





demonstrated good baseline agreement. The current study extends the scant hfPWV literature 
by reporting that cfPWV and hfPWV demonstrate strong agreement when tracking acute changes 
in central arterial stiffness.  
 
Measures of hfPWV are inherently lower than cfPWV. It may be possible to correct hfPWV to 
ensure greater comparability with cfPWV, however such corrections may limit measurement 
precision. Although there is some divergence in absolute PWV values, hfPWV and cfPWV are 
proportionate to one another. It is recognized that hfPWV measures still require assessment of 
the femoral artery. Like the carotid artery, femoral artery assessments can also be challenging 
and may require a highly trained operator to ensure precision, particularly when using ultrasound 
or tonometry technologies. One emerging technique which is operator independent and has 
demonstrated moderate agreement with cfPWV (r = 0.64) is the determination of hfPWV using an 
oscillometric thigh cuff to detect femoral waveforms [22]. Further exploration of this technology is 
required, but the simplicity of the oscillometric-based hfPWV measures may encourage the 
clinical adoption of central arterial stiffness phenotyping as a marker of arterial ageing and CVD 
risk. Regardless of approach, future work should seek to identify the repeatability of hfPWV 
measures and if hfPWV and cfPWV similarly track central arterial stiffness changes in older adults 
with CVD progression. 
 
CONCLUSIONS 
The current findings indicate that cfPWV and hfPWV are strongly associated, and that change in 
cfPWV is very strongly associated with change in hfPWV following the acute perturbation of 
central arterial stiffness. Accordingly, hfPWV may be a simple, viable alternative to cfPWV in the 
tracking of CVD risk within clinical and epidemiological environments.  
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